TCM
DMTK

Traynor Capital Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Traynor Capital Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-70,500
Closed -$123K – 307
2023
Q4 		$123K Hold
70,500
– – 0.01% 213
2023
Q3 		$102K Buy
70,500
+30,500
+76% +$76.3K 0.01% 197
2023
Q2 		$104K Buy
40,000
+14,000
+54% +$41.9K 0.01% 193
2023
Q1 		$95.7K Buy
26,000
+16,000
+160% +$67.4K 0.01% 188
2022
Q4 		$17.7K Buy
+10,000
New +$26.6K ﹤0.01% 209

Other funds holding DMTK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return

Traynor Capital Management's DMTK Position: Q1 2024 in Review

Traynor Capital Management sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2024, closing a stake of 10,386 shares — an estimated $18.2K sold.

Traynor Capital Management first reported a position in DMTK in Q4 2022 and held it in 5 quarters. The position peaked at $22.4K in Q1 2023. 69 funds tracked by Wall St. Rank hold DMTK as of Q1 2024.

  • Traynor Capital Management reported no remaining DermTech, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Traynor Capital Management sold 10,386 DermTech, Inc. Common Stock shares in Q1 2024, an estimated $18.2K.
  • Traynor Capital Management first reported a position in DermTech, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
  • Traynor Capital Management's DermTech, Inc. Common Stock position peaked at $22.4K in Q1 2023.
  • 69 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2024.

Based on Traynor Capital Management's 13F filing for Q1 2024, filed 12 Apr 2024.